Gene therapy player Cellogen Therapeutics raises $2-M from Natco Pharma

Publicly listed Natco Pharma has invested approximately USD 2 million in Cellogen Therapeutics Pvt Ltd , a Delhi-based biotech startup.Cellogen is primarily involved in two R&D programmes involving cell and gene therapy solutions. CAR T cell therapy programme is at an advanced stage for Cellogen Therapeutics where the T cells of the patients are genetically engineered to identify and kill the cancer cells.